• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyloxycarbonyls

Comprehensive Overview of (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester (CAS No. 1353971-24-0)

(4-Methylamino-cyclohexyl)-carbamic acid benzyl ester (CAS No. 1353971-24-0) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, often referred to as a cyclohexyl carbamate derivative, is characterized by its unique structural features, including a benzyl ester group and a methylamino-cyclohexyl moiety. Its molecular formula and precise weight make it a subject of interest for researchers exploring novel drug intermediates and bioactive molecules.

The chemical properties of (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester include its solubility in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, which facilitates its use in laboratory settings. Its stability under controlled conditions makes it suitable for various synthetic applications. Researchers often investigate its reactivity and potential as a building block in the synthesis of more complex molecules, particularly in the development of central nervous system (CNS) targeting compounds.

One of the key applications of (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester lies in its role as a pharmaceutical intermediate. It is frequently utilized in the synthesis of compounds with potential therapeutic effects, such as neuromodulators or enzyme inhibitors. Recent studies have explored its utility in designing molecules that interact with specific receptors, which could lead to breakthroughs in treating neurological disorders. This aligns with the growing interest in precision medicine and targeted drug delivery systems, which are hot topics in modern pharmacology.

From a market perspective, the demand for (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester is driven by its niche applications in drug discovery and development. Pharmaceutical companies and research institutions are increasingly seeking high-purity versions of this compound to support their R&D efforts. The rise of AI-driven drug discovery platforms has further amplified interest in such specialized intermediates, as they are often used in high-throughput screening and computational modeling.

In terms of safety and handling, (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester should be stored in a cool, dry environment, away from direct sunlight. While it is not classified as a hazardous material under standard regulations, proper laboratory practices, including the use of personal protective equipment (PPE), are recommended when handling this compound. Researchers often inquire about its material safety data sheet (MSDS) and storage conditions, which are critical for ensuring safe usage.

The synthetic pathways for producing (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester typically involve multi-step organic reactions, including amination and esterification processes. Advanced techniques such as microwave-assisted synthesis and catalysis have been explored to improve yield and efficiency. These innovations are part of the broader trend toward green chemistry and sustainable manufacturing practices in the chemical industry.

Looking ahead, the potential of (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester in drug development and biochemical research remains promising. Its structural versatility and compatibility with various synthetic methodologies position it as a valuable tool for scientists. As the field of medicinal chemistry continues to evolve, compounds like this will likely play a pivotal role in discovering next-generation therapeutics.

For researchers and industry professionals seeking detailed information about (4-Methylamino-cyclohexyl)-carbamic acid benzyl ester, it is advisable to consult peer-reviewed journals, patent databases, and specialized chemical suppliers. The compound's CAS No. 1353971-24-0 serves as a unique identifier, ensuring accurate sourcing and regulatory compliance. With ongoing advancements in chemical informatics and data-driven research, access to reliable information about such compounds has become more streamlined than ever.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)